Association of FKBP5 gene haplotypes with completed suicide in the Japanese population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 1, 2011, Pages 252-256

  Supriyanto, Irwan ^a   Sasada, Toru ^a   Fukutake, Masaaki ^a   Asano, Migiwa ^a   Ueno, Yasuhiro ^a   Nagasaki, Yasushi ^b   Shirakawa, Osamu ^c   Hishimoto, Akitoyo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Medical Examiner's Office of Hyogo Prefecture   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FK506 binding protein 5; Glucocorticoid receptor; HPA axis; Mineralocorticoid receptor; Suicide

Indexed keywords

FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; JAPAN; MALE; MIDDLE AGED; MOOD DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID; SUICIDE; TACROLIMUS BINDING PROTEINS;

EID: 78650942680     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.11.019     Document Type: Article

References (52)

1. Barret J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
2. Beautrais A.L., Joyce P.R., Mulder R.T., Fergusson D.M., Deavoll B.J., Nightingale S.K. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry 1996, 153:1009-1014.
3. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrynology 2009, 34S:S186-S195.
4. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Gen 2004, 36:1319-1325.
5. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299(11):1291-1305.
6. Brent D.A., Mann J.J. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C 2005, 133C:13-24.
7. Brent D., Melhem N., Ferrell R., Emslie G., Wagner K.D., Ryan N., et al. Association of FKBP5 polymorphisms with suicidal events in the treatment of resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2010, 167:190-197.
8. Claes S. Glucocorticoid receptor polymorphisms in major depression. Ann NY Acad Sci 2009, 1179:216-228.
9. Coryell W. DST abnormality as a predictor of course in major depression. J Affect Disord 1990, 19:163-169.
10. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001, 158:748-753.
11. De Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6:463-475.
12. De Luca V., Tharmalingam S., Zai C., Potapova N., Strauss J., Vincent J., et al. Association of HPA axis genes with suicidal behavior in schizophrenia. J Psychopharmacol 2010, 1-6. Epub.
13. De Rijk R.H. Single nucleotide polymorphism related to HPA axis reactivity. Neuroimmunomodulation 2009, 16:340-352.
14. De Rijk R., De Kloet E.R. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 2005, 28(3):263-269.
15. De Rijk R., De Kloet E.R. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol 2008, 583:303-311.
16. De Rijk R.H., Wust S., Meijer O.C., Zennaro M.C., Federenko I.S., Hellhammer D.H., et al. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006, 91:5083-5089.
17. De Rijk R.H., van Leeuwen N., Klok M.D., Zitman F.G. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur J Pharmacol 2008, 585:492-501.
18. Dorovini-Zis K., Zis A.P. Increased adrenal weight in victims of violent suicide. Am J Psychiatry 1987, 144:1214-1215.
19. Dumser T., Barocka A., Schubert E. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol 1998, 19:72-76.
20. Dupont W.D., Plummer W.D. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998, 19:589-601.
21. Ernst C., Mechawar N., Turecki G. Suicide neurobiology. Prog Neurobiol 2009, 89:315-333.
22. Giegling I., Olgiati P., Hartmann A.M., Calati R., Moller H.J., Rujescu D., et al. Personality and attempted suicide. Analysis of aggression and impulsivity. J Psychiatry Res 2009, 43:1262-1271.
23. Inder W.J., Donald R.A., Prickett T.C.R., Frampton C.M., Sullivan P.F., Mulder R.T., et al. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol Psychiatry 1997, 42:744-747.
24. Jokinen J., Nordstrom P. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 2008, 33:1387-1393.
25. Jokinen J., Nordstrom P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord 2009, 116:117-120.
26. Jokinen J., Carlborg A., Martensson B., Forslund K., Nordstrom A.L., Nordstrom P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 2007, 150:297-303.
27. Lekman M., Laje G., Charney D., Rush A.J., Wilson A.F., Sorant A.J.M., et al. The FKBP5-gene in depression and treatment response-an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort. Biol Psychiatry 2008, 63:1103-1110.
28. Lindqvist D., Isaksson A., Traskman-Bendz L., Brundin L. Salivary cortisol and suicidal behavior-a follow-up study. Psychoneuroendocrin 2008, 33:1061-1068.
29. Lindqvist D., Traskman-Bendz L., Vang F. Suicidal intent and the HPA-axis characteristics of suicide attempters with major depressive disorder and adjustment disorders. Arch Suicide Res 2008, 12:197-207.
30. Mann J.J. Neurobiology of suicide. Nat Med 1998, 4:25-30.
31. Mann J.J. Neurobiology of suicidal behavior. Nat Rev Neurosci 2003, 4:819-828.
32. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int J Neuropsychopharmacol 2006, 9:465-474.
33. McGowan P., Sasaki A., D'Alessio C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
34. Pfeffer C.R., Stokes P., Shindledecker R. Suicidal behavior and hypothalamic-pituitary-adrenocortical axis indices in child psychiatric inpatients. Biol Psychiatry 1991, 29:909-917.
35. Pfennig A., Kunzel H.E., Kern N., Ising M., Majer M., Fuchs B., et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005, 57:336-342.
36. Robins E., Murphy G.E., Wilkinson R.H., Gassner S., Kayes J. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health Nations Health 1959, 49:888-899.
37. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry 1992, 32:812-816.
38. Roy A., Rylander G., Sarchiapone M. Genetics of suicides. Family studies and molecular genetics. Ann N Y Acad Sci 1997, 836:135-157.
39. Roy A., Gorodetsky E., Yuan Q., Goldman D., Enoch M.A. Interaction of FKBP5 gene, a stress related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010, 35:1674-1683.
40. Rujescu D., Thalmeier A., Moller H.J., Bronisch T., Giegling I. Molecular genetic findings in suicidal behavior: what is beyond the serotonergic system?. Arch Suicide Res 2007, 11:17-40.
41. Sarginson J.E., Lazzeroni L.C., Ryan H.S., Schatzberg A.F., Murphy G.M. FKBP5 polymorphisms and antidepressant response in geriatric depression. Am J Med Genet B 2009, 153B:554-560.
42. Shaffer D., Gould M.S., Fisher P., Trautman P., Moreau D., Kleinman M., et al. Psychiatric diagnosis in child and adolescent suicide. Arc Gen Psychiatry 1996, 53:339-348.
43. Szigethy E., Conwell Y., Forbes N.T., Cox C., Caine E.D. Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry 1994, 36:374-380.
44. Targum S.D., Rosen L., Capodanno A.E. The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 1983, 140:877-879.
45. Tatro E.T., Everall I.P., Masliah E., Hult B.J., Lucero G., Chana G., et al. Differential expression of immunophilins FKBP51and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder. J Neuroimmune Pharmacol 2009, 4:218-226.
46. Tatro E.T., Everall I.P., Kaul M., Achima C.L. Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res 2009, 1286:1-12.
47. Van Heeringen K. The neurobiology of suicide and suicidality. Can J Psychiatry 2003, 48(5):292-300.
48. Van Heeringen K., Audenaert K., Wiele L.V., Verstraete A. Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J Affect Disord 2000, 60:181-189.
49. Van Leeuwen N., Kumsta R., Entringer S., De Kloet R.E., Zitman F.G., De Rijk R.H., et al. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrin 2010, 35(3):339-349.
50. Westrin A. Stress system alterations and mood disorders in suicidal patients. A review. Biomed Pharmacother 2000, 54:142-145.
51. Westrin A., Ekman R., Traskman-Bendz L. Alterations of corticotrophin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol 1999, 9:205-211.
52. World Health Organization Burden of mental and behavioral disorders: suicide http://www.who.int/whr/2001/chapter2/en/index6.html.